US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Michael Mullette

Recent news which mentions Michael Mullette

Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
Tickers CMPS NEWS
Tags Benzinga Amy Emerson News
From Benzinga
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
Tickers AWKNF
Tags Financing Global Management
From Benzinga
Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy
Tickers MAPS
Tags Cannabis Michael Mullette MNRA
From Benzinga